Biocartis

Our Mission & Vision

Biocartis’ vision is to enable personalized medicine for patients around the world through universal access to molecular testing. Our mission is to make molecular testing actionable, easy, fast and suitable for any lab.

Meet Idylla

Idylla^TM - A revolutionary, fully automated system that makes molecular testing easy, fast and suitable for any lab.

Oncology

Molecular biomarker results in only 3 hours for fast treatment decisions!

THINK IDYLLA™

Oncology Research

Biocartis encourages the research into new and emerging uses of different biomarkers.

Partnering

Biocartis believes in the power of collaboration and has partnership programs with pharmaceutical and diagnostic or biomarker companies

Disease area oncology

Lung Cancer

Colorectal Cancer

Melanoma

Distributed by Biocartis

APIS ESR1 Mutations Kit

The APIS ESR1 Mutations Kit is an advanced qPCR assay for the sensitive and precise detection of mutations within the oestrogen receptor gene. The APIS ESR1 Mutations Kit is a qualitative test, detecting eleven ESR1 mutations across three exons: exon 5 (E380Q), exon 7 (S463P) and exon 8 (P535H, L536R, L536Q, L536H, L536P, Y537C, Y537S, Y537N and D538G).

APIS Breast Cancer Subtyping Kit

The APIS Breast Cancer Subtyping Kit is a highly reproducible, RNA-based diagnostic workflow for detecting mRNA expression of standard biomarkers (ER, PR, HER2, Ki67) and novel proliferative biomarkers from pre-operative core-needle biopsy (CNB) or resected formalin-fixed paraffin-embedded (FFPE) breast tumour tissue.

Idylla ThyroidPrint® Assay

First-in-class cartridge-based assay for risk stratification of indeterminate thyroid nodules.

Merlin™ Assay

Merlin helps identify melanoma patients who have a low risk for nodal metastasis and may forgo the sentinel lymph node biopsy (SLNB).

HepatoPredict

HepatoPredict employs a machine learning algorithm combing tumor gene expression with clinical variables to accurately identify hepatocellular carcinoma patients for liver transplantation.